Cybin Inc (NY: CYBN )
0.2522 UNCHANGED Streaming Delayed Price Updated: 8:00 PM EDT, Jun 6, 2023 Add to My Watchlist
All News about Cybin Inc
Cybin to Present at the Jefferies Healthcare Conference
June 01, 2023
Microdosing LSD For Major Depression Treatment Seeks Further Clinical Validation Via New Study Australian psychedelics company MindBio Therapeutics Corp. was granted approval by both the Ethics...
Novel DMT Compound For Anxiety Shows Clinical Progress: Robust Effects Within 2 Minutes
May 24, 2023
Canadian clinical-stage psychedelics company Cybin Inc. (NYSE: CYBN) announced that the first group of participants have been dosed with its proprietary deuterated DMT molecule, CYB004, in an ongoing
Psyched: $20M Research Fund, LSD Microdosing For Cancer, MEAI Enters Clinical Stage, Reform Update & More
May 15, 2023
Researchers At Johns Hopkins Get $20M Fund Prompted By Longtime Psychedelics Scientist Johns Hopkins University academics received a boost in funding thanks to the recently launched Roland R. Griffiths...
Trial On DMT Drug For Anxiety And Depression Ends Participant Dosing, Study Results Soon Released
May 09, 2023
Clinical-stage biopharma company Cybin Inc. (NYSE: CYBN) has completed participant dosing on the part 2 of 3 of its Phase 1 trial assessing intravenous (IV) administration of proprietary DMT drug...
April Psychedelic Drug Stocks Recap: The Ups And Downs
April 30, 2023
Via Talk Markets
Cybin, Mind Medicine Among Top Psychedelic Movers Of Today
April 19, 2023
Psychedelic Stock Gainers And Losers From April 18, 2023
April 18, 2023
Psychedelic Stock Gainers And Losers From April 17, 2023
April 17, 2023
Psychedelic Stock Gainers And Losers From April 13, 2023
April 13, 2023
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following